Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Cardiology
•
Interventional Cardiology
•
Hospital Medicine
Following left main bifurcation stenting, do you routinely proceed with kissing balloon inflation of the side branch, either LCx or LAD?
Answer from: at Community Practice
It depends on the technique used; most crush based techniques require kissing balloon inflation.
Comments
at The George Washington University Hospital
Routinely, yes.
14471
Sign In
or
Register
to read more
Answer from: at Community Practice
Simple answer, yes. Complexities exist that could modify the approach, but in general, ensuring the bifurcation is maximally dilated is my preferred technique.
Sign In
or
Register
to read more
Answer from: at Academic Institution
Yes
Sign In
or
Register
to read more
Answer from: at Community Practice
It is ideal to do it. Sometimes, however, it may not be feasible.
Sign In
or
Register
to read more
Answer from: at Community Practice
Most of the time but again depends on lesson and which technique I used.
Sign In
or
Register
to read more
Answer from: at Community Practice
Ideally, yes.
Sign In
or
Register
to read more
Answer from: at Community Practice
The answer is yes. One must do kissing balloons after complex LM bifurcation stenting unless it is technically not possible.
Sign In
or
Register
to read more
20782
20992
21415
21488
21483
22325
26106
Related Questions
Do you pursue stress testing before discharge for a patient admitted with chest pain who has negative serial high-sensitivity troponins and a low HEART score?
Do you routinely condition the implantation of a microaxial flow pump upon echocardiographic exclusion of left ventricular thrombus?
What is your approach when a patient has concomitant acute decompensated heart failure and rapid atrial fibrillation?
Have you changed your approach to delaying hip surgery in the context of decompensated CHF given the findings of the HIP-ATTACK study?
When would you consider switching to or adding on a PCSK9 inhibitor to lipid-lowering therapy following hospital discharge for acute coronary syndrome, in light of the results of the VICTORION-INCEPTION trial, provided LDL is still not at goal?
What is your diagnostic and therapeutic approach to hospitalized patients with persistent hypotension (MAP <65) of uncertain etiology, but no evidence of hypoperfusion or shock physiology?
How do you decide between atorvastatin versus rosuvastatin and their high-intensity doses for statin-naive patients following a STEMI and PCI?
Would you consider amiodarone for the treatment of atrial fibrillation with RVR in patients who cannot tolerate beta blockers but have a high CHA2DS2-VASc score and are not on anticoagulation?
Do you ever consider sodium supplementation to augment diuresis in patients hospitalized with decompensated heart failure, as discussed in a recent systematic review and meta-analysis?
Under what circumstances would you consider withdrawing aspirin and continuing with potent P2Y12 inhibitor monotherapy after successful PCI in patients with acute coronary syndromes, based on the findings of the NEO-MINDSET trial?
Routinely, yes.